HemaSphere (Jun 2022)

P573: PHARMACOKINETIC EXPOSURE EQUIVALENCE AND PRELIMINARY EFFICACY AND SAFETY FROM A RANDOMIZED CROSS OVER PHASE 3 STUDY OF AN ORAL HYPOMETHYLATING AGENT DEC-C COMPARED TO IV DECITABINE IN AML PATIENTS

  • K. Geissler,
  • Z. Koristek,
  • T. Bernal del Castillo,
  • J. Novák,
  • G. Rodriguez Macias,
  • S. K. Metzelder,
  • A. Illes,
  • A. Nagy,
  • J. Mayer,
  • M. Arnan,
  • M.-M. Keating,
  • J. Krauter,
  • M. Lunghi,
  • N. Stefano Fracchiolla,
  • U. Platzbecker,
  • V. Santini,
  • Y. Sano,
  • A. Oganesian,
  • H. Keer,
  • M. Lübbert

DOI
https://doi.org/10.1097/01.HS9.0000845180.87968.2a
Journal volume & issue
Vol. 6
pp. 472 – 473

Abstract

Read online

No abstracts available.